Antithrombotic therapy for venous thromboembolic disease

Chest. 1995 Oct;108(4 Suppl):335S-351S. doi: 10.1378/chest.108.4_supplement.335s.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Drug Monitoring
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / economics
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Risk Factors
  • Thromboembolism / drug therapy*
  • Thromboembolism / economics
  • Thrombolytic Therapy* / economics
  • Time Factors

Substances

  • Fibrinolytic Agents